Synovics Pharmaceuticals, Inc.
OTC: SYVC0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Christopher J. Flynn
- Employees
- 155
- Headquarters
- Fort Lauderdale, United States
- IPO year
- 2004
- Market cap
- $3.0K
- Website
- https://www.synovics.com
Loading SYVC…
Loading profile data…Frequently asked questions about SYVC
What does Synovics Pharmaceuticals, Inc. (SYVC) do?
Synovics Pharmaceuticals, Inc., through its subsidiaries, engages in the development, manufacture, and commercialization of generic over-the-counter (OTC) pharmaceutical products and generic prescription drug products primarily in the United States. The company’s OTC product categories include analgesics, cough, cold, antihistamines, asthma reli...
Where does SYVC trade?
Synovics Pharmaceuticals, Inc. (SYVC) trades on the Other OTC.
What sector is SYVC in?
Synovics Pharmaceuticals, Inc. (SYVC) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Synovics Pharmaceuticals, Inc.?
Christopher J. Flynn is the chief executive officer of Synovics Pharmaceuticals, Inc. (SYVC).
Where is Synovics Pharmaceuticals, Inc. headquartered?
Synovics Pharmaceuticals, Inc. is headquartered in United States.
Does SYVC pay a dividend?
Synovics Pharmaceuticals, Inc. (SYVC) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did SYVC go public?
Synovics Pharmaceuticals, Inc. (SYVC) completed its initial public offering in 2004.